跳至主要内容
临床试验/CTIS2023-505153-41-00
CTIS2023-505153-41-00进行中(未招募)1 期

Randomized, open-label, single dose, four-period, cross-over drug-drug interaction study comparing reference products Crestor 20 mg film coated tablets, Norvasc 10 mg tablets and Tritace 10 mg tablets administrated concomitantly versus each drug administrated alone in healthy male and female subjects under fasting conditions.

Adamed Pharma S.A.0 个研究点目标入组 60 人开始时间: 2023年5月25日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60